Femasys (FEMY) Return on Capital Employed (2021 - 2025)
Femasys (FEMY) posted Return on Capital Employed of 746.57% for Q2 2025, down 13.97% on a QoQ basis from 655.03% in Q1 2025, and down 66361.0% year-over-year from N/an in Q2 2024.
Femasys (FEMY) Return on Capital Employed (2021 - 2025) Analysis & Trends
Femasys' Return on Capital Employed history runs 5 years deep, the most recent figure standing at 746.57% for Q2 2025.
- Quarterly Return on Capital Employed fell 66361.0% year-over-year to 746.57% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 746.57% (down 66361.0% YoY) and the FY2025 annual result came in at 135.84%, up 1859.0% from the prior year.
- Return on Capital Employed was 746.57% for Q2 2025 at Femasys, down from 655.03% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 24.85% in Q3 2021 and bottomed at 746.57% in Q2 2025.
- A 5-year average of 163.46% and a median of 81.23% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 2120 bps — and 2025, when it tumbled 66361 bps.
- Femasys' Return on Capital Employed stood at 29.59% in 2021, then plunged by 132 bps to 68.49% in 2022, then fell by 16 bps to 79.5% in 2023, then sank by 312 bps to 327.42% in 2024, then plunged by 128 bps to 746.57% in 2025.
- Business Quant data shows FEMY's Return on Capital Employed at 746.57% in Q2 2025, 655.03% in Q1 2025, and 327.42% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -746.57% |
| Mar 31, 2025 | -655.03% |
| Dec 31, 2024 | -327.42% |
| Sep 30, 2024 | -116.26% |
| Jun 30, 2024 | -82.96% |
| Mar 31, 2024 | -62.98% |
| Dec 31, 2023 | -79.50% |
| Sep 30, 2023 | -105.34% |
| Jun 30, 2023 | -94.69% |
| Mar 31, 2023 | -84.18% |
| Dec 31, 2022 | -68.49% |
| Sep 30, 2022 | -55.43% |
| Jun 30, 2022 | -45.20% |
| Mar 31, 2022 | -36.95% |
| Dec 31, 2021 | -29.59% |
| Sep 30, 2021 | -24.85% |